Multiplex Assay Kit for Cluster Of Differentiation 4 (CD4) ,etc. by FLIA (Flow Luminescence Immunoassay)

CD4mut; p55; T-cell surface glycoprotein CD4; T-cell surface antigen T4/Leu-3

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Cluster Of Differentiation 4 (CD4) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Cluster Of Differentiation 4 (CD4) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Cluster Of Differentiation 4 (CD4) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Cluster Of Differentiation 4 (CD4) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 83-101 98
EDTA plasma(n=5) 87-95 91
heparin plasma(n=5) 78-103 88
sodium citrate plasma(n=5) 95-102 99

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Cluster Of Differentiation 4 (CD4) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Cluster Of Differentiation 4 (CD4) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Cluster Of Differentiation 4 (CD4) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 95-103% 80-96% 79-90% 91-98%
EDTA plasma(n=5) 97-105% 83-94% 79-98% 83-104%
heparin plasma(n=5) 93-105% 84-92% 80-98% 95-103%
sodium citrate plasma(n=5) 79-90% 80-88% 83-99% 90-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:CD4) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Taylor & Francis Influences of Hyriopsis cumingii polysaccharides on mice immunosignaling molecules and T lymphocyte differentiation 09540105.2017.1306494
anticancer research Adjuvant Postoperative CD40 Agonist and PD-1 Antagonist Combination Therapy in Syngeneic Tongue Cancer Mouse Model Pubmed: 32366416
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB167Hu01 Recombinant Cluster Of Differentiation 4 (CD4) Positive Control; Immunogen; SDS-PAGE; WB.
PAB167Hu01 Polyclonal Antibody to Cluster Of Differentiation 4 (CD4) WB; IHC; ICC; IP.
FAB167Hu01 Anti-Cluster Of Differentiation 4 (CD4) Polyclonal Antibody Flow cytometry.
LAB167Hu71 Biotin-Linked Polyclonal Antibody to Cluster Of Differentiation 4 (CD4) WB; IHC; ICC.
FAB167Hu41 PE-Linked Anti-Cluster Of Differentiation 4 (CD4) Polyclonal Antibody Flow cytometry.
FAB167Hu51 APC-Linked Anti-Cluster Of Differentiation 4 (CD4) Polyclonal Antibody Flow cytometry.
FAB167Hu81 FITC-Linked Anti-Cluster Of Differentiation 4 (CD4) Polyclonal Antibody Flow cytometry.
MAB167Hu22 Monoclonal Antibody to Cluster Of Differentiation 4 (CD4) WB; IHC; ICC; IP.
RAB167Hu22 Recombinant Antibody to Cluster Of Differentiation 4 (CD4) WB; IF; ICC; IHC; IP; FCM.
MAB167Hu23 Monoclonal Antibody to Cluster Of Differentiation 4 (CD4) WB; IHC; ICC; IP.
MAB167Hu24 Monoclonal Antibody to Cluster Of Differentiation 4 (CD4) WB; IHC
MAB167Hu21 Monoclonal Antibody to Cluster Of Differentiation 4 (CD4) WB; IHC; ICC; IP.
RAB167Hu21 Recombinant Antibody to Cluster Of Differentiation 4 (CD4) WB; IHC; ICC.
FAB167Hu02 Anti-Cluster Of Differentiation 4 (CD4) Monoclonal Antibody Flow cytometry.
FAB167Hu42 PE-Linked Anti-Cluster Of Differentiation 4 (CD4) Monoclonal Antibody FCM
FAB167Hu52 APC-Linked Anti-Cluster Of Differentiation 4 (CD4) Monoclonal Antibody Flow cytometry.
FAB167Hu82 FITC-Linked Anti-Cluster Of Differentiation 4 (CD4) Monoclonal Antibody Flow cytometry.
SEB167Hu ELISA Kit for Cluster Of Differentiation 4 (CD4) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB167Hu Multiplex Assay Kit for Cluster Of Differentiation 4 (CD4) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSB167Hu01 ELISA Kit DIY Materials for Cluster Of Differentiation 4 (CD4) Main materials for "Do It (ELISA Kit) Yourself".